Minireviews
Copyright ©The Author(s) 2016.
World J Radiol. Sep 28, 2016; 8(9): 799-808
Published online Sep 28, 2016. doi: 10.4329/wjr.v8.i9.799
Figure 7
Figure 7 4’-[methyl-11C]-thiothymidine uptake in oligodendroglioma. A patient was diagnosed with grade 2 astrocytoma during the initial operation. At the 1-year follow-up, an enhanced lesion appeared on MRI and 11C-MET uptake increased around the initially resected lesion. These findings suggested that the malignant transformation of astrocytoma occurred. However, 11C-4DST uptake into the tumor was not different from basal brain levels. The pathological diagnosis at the second operation was grade 2 oligodendrocytoma with a newly appearing oligodendroglioma component, but without malignant transformation. Reprinted from Nariai et al[14], with the permission of Springer. 11C-4DST: 4’-[methyl-11C]-thiothymidine; 11C-MET: 11C-Methionine; Gd-MRI: Gadolinium-enhanced magnetic resonance image.